We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$11.9B
AUM Growth
+$2.55B
Cap. Flow
+$1.81B
Cap. Flow %
15.19%
Top 10 Hldgs %
28.34%
Holding
1,181
New
44
Increased
774
Reduced
301
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 34.81%
2 Financials 13.96%
3 Healthcare 11.37%
4 Energy 7.72%
5 Consumer Discretionary 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMG icon
526
Chipotle Mexican Grill
CMG
$47.2B
$2.39M 0.02%
86,200
+22,800
+36% +$681K
IBRX icon
527
ImmunityBio
IBRX
$7.51B
$2.39M 0.02%
471,523
+67,083
+17% +$368K
WWD icon
528
Woodward
WWD
$21.3B
$2.39M 0.02%
24,711
+4,369
+21% +$404K
TT icon
529
Trane Technologies
TT
$100B
$2.38M 0.02%
14,154
+6,795
+92% +$1.12M
NEM icon
530
Newmont
NEM
$98.7B
$2.37M 0.02%
50,291
+19,988
+66% +$892K
KPTI icon
531
Karyopharm Therapeutics
KPTI
$43.5M
$2.37M 0.02%
46,444
+1,910
+4% +$132K
CTVA icon
532
Corteva
CTVA
$52.6B
$2.35M 0.02%
39,961
+19,761
+98% +$1.25M
SGMO
533
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.34M 0.02%
743,903
+304,949
+69% +$1.18M
COR icon
534
Cencora
COR
$60.6B
$2.31M 0.02%
13,970
+5,671
+68% +$896K
PMVP icon
535
PMV Pharmaceuticals
PMVP
$59.2M
$2.3M 0.02%
264,772
-24,546
-8% -$262K
ZBH icon
536
Zimmer Biomet
ZBH
$18.2B
$2.3M 0.02%
18,038
+6,800
+61% +$789K
PH icon
537
Parker-Hannifin
PH
$123B
$2.29M 0.02%
7,866
+3,767
+92% +$1.08M
LUV icon
538
Southwest Airlines
LUV
$22B
$2.27M 0.02%
67,567
+18,823
+39% +$679K
CPAY icon
539
Corpay
CPAY
$25B
$2.24M 0.02%
12,200
+2,024
+20% +$371K
CBRE icon
540
CBRE Group
CBRE
$42.5B
$2.22M 0.02%
28,787
+9,722
+51% +$718K
BAX icon
541
Baxter International
BAX
$13.5B
$2.21M 0.02%
43,412
+16,442
+61% +$883K
ED icon
542
Consolidated Edison
ED
$40.1B
$2.2M 0.02%
23,133
+9,948
+75% +$905K
YUM icon
543
Yum! Brands
YUM
$41.8B
$2.2M 0.02%
17,157
+7,427
+76% +$900K
EGY icon
544
Vaalco Energy
EGY
$570M
$2.19M 0.02%
+480,697
New +$2.41M
ANAB icon
545
AnaptysBio
ANAB
$1.58B
$2.18M 0.02%
70,294
-7,366
-9% -$208K
BWXT icon
546
BWX Technologies
BWXT
$15.5B
$2.18M 0.02%
37,467
+6,629
+21% +$381K
LNC icon
547
Lincoln National
LNC
$8.73B
$2.17M 0.02%
70,743
+6,702
+10% +$266K
PNT
548
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$2.17M 0.02%
297,378
+148,802
+100% +$1.1M
SYY icon
549
Sysco
SYY
$40.8B
$2.17M 0.02%
28,349
+14,037
+98% +$1.13M
DAY
550
DELISTED
Dayforce
DAY
$2.16M 0.02%
33,706
+3,327
+11% +$209K

Similar funds

Rafferty Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Rafferty Asset Management held 1,181 positions worth $11.9B, up 27% from $9.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rafferty Asset Management deployed $1.81B of net new capital in Q4 2022, opening 44 new positions and adding to 774 existing holdings. Its largest new stake was Akero Therapeutics: 187,799 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Microchip Technology, an estimated $12.3M trimmed.

  • Rafferty Asset Management's largest Q4 2022 buy was Akero Therapeutics: 187,799 shares worth $10.3M.
  • Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2022, an estimated $294M increase.
  • Rafferty Asset Management's biggest Q4 2022 reduction was Microchip Technology, cutting an estimated $12.3M.
  • Rafferty Asset Management fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $7.53M.
  • Rafferty Asset Management's ten largest holdings make up 28% of its $11.9B portfolio in Q4 2022.
  • Rafferty Asset Management opened 44 new positions and closed 61 in Q4 2022.
  • Rafferty Asset Management's portfolio value rose 27% quarter-over-quarter to $11.9B.

Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.